JYHB2100110 | 利格列汀片 | linagliptin | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-02-02 | view |
JXHL2100020 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-18 | view |
JXHL2100018 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-18 | view |
JXHL2100019 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-18 | view |
JYHB2100070 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-01-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2021-02-01 | view |
JXHL2100015 | BI 425809 片 | iclepertin | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-16 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-15 | view |
JXHL2000359 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000358 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000357 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000356 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000360 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JYHB2002711 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-29 | view |
JYHB2002710 | 利格列汀二甲双胍片(Ⅱ) | linagliptin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-29 | view |
JXSB2000052 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JXHL2000335 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JXHL2000339 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JXHL2000338 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JXSB2000053 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JXHL2000337 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
JYHB2002638 | 异丙托溴铵吸入气雾剂 | ipratropium bromide | Aerosol | Chemical Drugs | Supplementary Application | 2020-12-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |